Summary: Waltham, MA; General Obligation, Local GO Jul 97

  • ID: 2051926
  • July 1997
  • Standard & Poors
1 of 3

The rating upgrade on Waltham, Mass' bonds reflects: * The city's increasingly deep, diverse, and resurgent tax and economic base; * Solid financial position, even during the low point of the last recession; and * The expectation that debt will remain low and that capital needs will remain manageable. Waltham, population 54,791, is an attractive location for both residents and employers due to its excellent location along I-95 and Route 128 and its close proximity to Boston. The location along Route 128 has led to exceptionally low office vacancy rates (about 2% for class `A' space) and a boom in office construction along this well-known "high tech" highway. City officials believe that about 44% of the office space along Route...

Companies mentioned in this report are:
- Waltham

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

This product consists of a Summary Analysis: Bi-annual (at least). An abbreviated analysis containing Standard & Poor's issuer credit ratings as of the time the article was published. The analysis includes a rating rationale - the basis on which the rating was assigned - and an outlook section if the issuer is not on CreditWatch. Financial statistics are not included.

Note: Product cover images may vary from those shown
2 of 3


Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.